Market Research Report
|Published by||Global Industry Analysts, Inc.||Product code||341984|
|Published||Content info||211 Pages
Delivery time: 1-2 business days
|Published: January 1, 2021||Content info: 211 Pages||
In The Current You Can't Touch This World of COVID-19, Antibacterial Glass Gets a 10.8% Boost
The global market for Antibacterial Glass is expected to witness growth spike by over 10.8% in the year 2020. By the year 2027, the market is projected to reach US$409.6 million, trailing a post COVID-19 CAGR of 9.9% over the analysis period 2020 through 2027. The world stands on the brink of a crisis in infectious diseases. Cholera, malaria, tuberculosis, Ebola etc. represent perennial adversaries that keep coming back. Every year 18 to 20 million people die worldwide due to infectious diseases. The year 2020 stands out with COVID-19 alone resulting in 792,000 deaths in 7 months. With COVID-19 chief mode of transmission being contaminated surfaces, focus on anti-bacterial technologies, products & solutions, is growing stronger. Anti-bacterial glass is gaining new interest and adoption in construction, furniture and other self-cleaning surface application. Microbial growth and contamination is an issue affecting every aspect of life, from food and beverage and dairy processing, to pharmaceuticals and healthcare. Science has come a long way from the era when controlling such contamination was extremely difficult due to the lack of efficient infection control products. Over the years, dramatic rise in awareness about germs, mold and other undesirable bacteria/viruses that contaminate home, office, and hospital environment has led to a considerable rise in the adoption of solutions to control such bacteria. Of all the sectors, the case of infection control and prevention of microbial growth and contamination is perhaps the most acute in medical industry, given the high risk of and susceptibility to microbial growth in healthcare settings. Frequent contact with blood and other body fluids, continuous contact with patients, and invasive use of equipment in body cavities, make medical devices and instruments prone to microbial contamination. Contamination of surgical and diagnostic devices and instruments is a key reason for secondary infections in hospitalized patients, which increases their stay in hospitals, thereby adding to overall healthcare costs.
Over the years, there has been a surge in instances of contaminated medical devices, particularly of reports related to preloaded heparin syringes and sodium chloride intravenous catheter flushes getting contaminated with Pseudomonas fluorescens, and presumably leading to pseudobacteremia infections. The past few years have also been witness to numerous product recalls, as seen in the case of IV Flush LLC, which recalled several of its intravenous equipment following reports of contamination. Risk of infection due to intravenous equipment contamination continues to be a challenge for the medical community. Risk of bloodstream infections due to intravenous catheter contamination is more pronounced in developing countries. Conversely, staphylococci infection is the leading cause of catheter-related bloodstream infections in the US. Contaminated infusate or insertion port is also a major cause of infections, as it is transmitted due to handling of infusate by contaminated hands of medical staff of a hospital. Other possible reasons for infusate contamination include poor nursing standards, inadequate sterilization of the equipment, and inadequately chlorinated tap water. Contamination of injection ports of intravenous administration sets and intrinsic contamination of the infusate are also possible sources of contamination.
Anti-microbials are developed on the basic principle that prevention is better than cure. Designed to be sprayed onto a substrate, anti-microbial coatings on glass help in arresting growth and spread of infection-causing bacteria. They contain various types of biocompatible components, anti-drying chemicals, and lubricants that enable them to interact with body fluids and tissues to provide patient comfort and combat bacteria. Increasing focus on microbe-free products has created a strong market for anti-microbial coatings, which are also sometimes referred to as surface disinfectants. Benefits of such coating additives are being increasingly recognized in the areas of general hospital use, surgeries (both general and plastic), dentistry and cardiovascular medicine. High-quality anti-microbial glass coatings are growing in popularity for preventing formation of bacteria on medical devices. Coated glass has drastically evolved in last two decades with regard to design, functionality, and performance. Extensive research and development in the field of antimicrobial glass is anticipated to yield promising results. Antimicrobial glass is also emerging into a multifunctional and flexible solution to address COVID-19 challenges. Such coated glass is expected to minimize bacterial and virus spread through glass surfaces, specifically SARS-CoV-2 virus. Antimicrobial glass has an immense market potential in prevailing crisis. Frequently touched glass surfaces in public transport, schools, public offices, hospital, and others offer abundant growth opportunities for antibacterial glass. Coated glass is predicted to be the future of glass industry.
Select Competitors (Total 22 Featured) -